2024 / 11 / 06
We’re attending at
TIDES EUROPE 2024
Ajinomoto Bio-Pharma Services will participate in TIDES EUROPE 2024, held from Tuesday, November 12 to Thursday, November 14, 2024.
TIDES EUROPE is the industry’s leading event in Europe to accelerate therapeutics to market by expediting R&D, CMC efficiency, and building new partnerships across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies.
At the exhibition booth, a fully integrated CDMO, with sites in Belgium, United States, Japan, and India, providing cGMP manufacturing and drug product of small molecule and large molecule APIs and intermediates.
The latest technologies and services such as AJIPHASE®, AJICAP®, CORYNEX®, and TALAMAX® will be also introduced.
And we will be making the oral presentation about AJIPHASE® at the conference.
We look forward to your visit.
| Event Name | TIDES EUROPE 2024 |
|---|---|
| Dates | November 12(Tue) – 14(Thu), 2024 |
| Venue | Hamburg Congress Center / Hamburg, Germany |
| Exhibition | Booth 506 |
Oral Presentation
| Topics and Presenters | Enzymatic Oligonucleotide Manufacturing Combination with Solution Based Approach AJIPHASE® for Large Scale Daisuke Takahashi, PhD, Executive Specialist at Ajinomoto Co. Inc. |
|---|---|
| Executive Summary | Recent oligonucleotide drug discovery is attracting attention and the demand for oligonucleotides is growing worldwide. A practical manufacturing method for large volumes is strongly required. In particular, the method for double-stranded siRNA is in utmost demand since it requires twice the volume of manufacturing compared to single-stranded antisense oligonucleotides. We have established a solution for large-scale manufacturing by combining the solution-based synthetic AJIPHASE® method with an enzymatic approach to synthesize siRNA with high efficiency and high purity. This novel combination method will be updated. |
| Date, Time and Venue | November 14(Thu), 2024 13:25 – 13:55 |